Rukset Attar

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Glioblastoma (GBM) is the most common and aggressive intraparenchymal primary brain tumor in adults. The principal reasons for the poor outcomes of GBM are the high rates of recurrence and resistance to chemotherapy. The aim of this study was to determine the role of tailored cellular therapy for GBM with a poor prognosis and compare the activity of(More)
  • 1